Tulyp Medical Appoints Industry Veteran Steve Motes as CEO to Lead Next Phase of Growth in the US
Steve Motes brings deep expertise in Mechanical Circulatory Support (MCS) and early-stage company leadership
Company backed by Sofinnova Partners and leading medtech entrepreneurs and cardiologists
Tulyp Medical, a Paris-based medical device company developing an intelligent pressure-driven perfusion system, today announced the appointment of Steve Motes as Chief Executive Officer. The appointment follows positive results from the company’s first-in-human study.
Steve joins Tulyp with more than 30 years of experience in the medical device industry, primarily focused on cardiovascular technologies. He has held leadership roles at Draeger, Medtronic (formerly Somanetics), Edwards Lifesciences, and Abbott. At Abbott, he contributed to the launch of the HeartMate 3 LVAD system and played a key role in expanding the company’s ECMO business. More recently, he has served as CEO of several early-stage companies, including those in the MCS space.
